(Q46496531)

22 December 2017

title

Are statin medications safe in patients with ALS? (English)

1 reference

22 December 2017

amyotrophic lateral sclerosis

main subject

1 reference

Lorne Zinman

1

1 reference

22 December 2017

Reza Sadeghi

2

1 reference

22 December 2017

Marek Gawel

3

1 reference

22 December 2017

Dan Patton

4

1 reference

22 December 2017

Alex Kiss

5

1 reference

22 December 2017

publication date

1 August 2008

1 reference

22 December 2017

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

published in

1 reference

22 December 2017

volume

9

1 reference

22 December 2017

issue

4

1 reference

22 December 2017

page(s)

223-228

1 reference

22 December 2017

Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum

cites work

1 reference

https://api.crossref.org/works/10.1080%2F17482960802031092

Creatine kinase activity in amyotrophic lateral sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960802031092

Statin-induced rhabdomyolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960802031092

Statins in heart failure. Beyond the lipid lowering effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960802031092

Statin-associated myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960802031092

Genetic risk factors associated with lipid-lowering drug-induced myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960802031092

Peripheral neuropathy associated with simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960802031092

Lovastatin decreases coenzyme Q levels in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960802031092

Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960802031092

Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960802031092

Toward immunomodulatory and anti-inflammatory properties of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960802031092

The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960802031092

Phase II/III randomized trial of TCH346 in patients with ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960802031092

Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960802031092

Hypermetabolism in ALS: correlations with clinical and paraclinical parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960802031092

Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960802031092

Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17482960802031092

10.1080/17482960802031092

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

release_kbnacuypljbylkmc2t3wwdrpkm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kbnacuypljbylkmc2t3wwdrpkm

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

18608105

1 reference

22 December 2017